Antioxidant activity of fluoxetine: Studies in mice melanoma model

Cell Biochemistry and Function

Volumn 28, Issue 6, 2010, Pages 497-502

  Kirkova, Margarita ^a   Tzvetanova, Elina ^a   Vircheva, Stefani ^a   Zamfirova, Rositsa ^a   Grygier, Beata ^b   Kubera, Marta ^b  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antioxidant enzyme activities; Fluoxetine; Glutathione; Lipid peroxidation; Melanoma

Indexed keywords

FLUOXETINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROXYL GROUP; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIOXIDANTS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FLUOXETINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; HYDROXYL RADICAL; MALE; MELANOMA; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; SPLEEN; SUPEROXIDE DISMUTASE;

ANIMALIA; MUS;

EID: 77956829454     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1682     Document Type: Article

References (47)

1. Heffner JA, Repine JE. State of the art: Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989; 140: 531-554.
2. Alho H, Leinonen JS, Erhola M, et al. Assay of antioxidant capacity of human plasma and CSF in aging and disease. Restor Neurol Neurosci 1998; 12: 159-165. (Pubitemid 28368297)
3. Latini A, Scussiato K, Rosa RB, et al. D-2-Hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats. Eur J Neurosci 2003; 17: 2017-2022.
4. Torres RL, Torres IL, Gamaro GD, et al. Lipid peroxidation and total radical-trapping potential of the lungs of rats submitted to chronic and sub-chronic stress. Braz J Med Biol Res 2004; 37(2): 185-192.
5. Woźniak A, Woźniak B, Drewa G, Drewa T. Lipid peroxidation and antioxidant capacity in selected tissues of healthy black C57BL/6J mice and B16 melanoma-bearing mice. Melanoma Res 2003; 13(1): 19-22.
6. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004; 44: 239-267.
7. Sander CS, Chang H, Hamm F, Elsner P, Thiele JJ. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol 2004; 43(5): 326-335.
8. Gadjeva V, Dimov A, Georgieva N. Influence of therapy on the antioxidant status in patients with melanoma. J Clin Pharm Ther 2008; 33(2): 179-185.
9. Yu J, Kim AK. Effect of taurine on antioxidant enzyme system in B16F10 melanoma cells. Adv Exp Med Biol 2009; 643: 491-499.
10. Gava B, Zorzet S, Spessotto P, Cocchietto M, Sava G. Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium transimidazoledimethylsulfoxide- tetrachlororuthenate and down-regulation of tumor cell invasion. J Pharmacol Exp Ther 2006; 317(1): 284-291.
11. Saleem M, Maddodi NM, Abu Zaid M, et al. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin Cancer Res 2008; 14: 2119-2127.
12. Meyskens FL, Chau HV Jr, Tohidian N, Buckmeier JA. Luminolenhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigment Cell Res 1997; 10: 184-189.
13. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004; 7(2): 97-110.
14. Fang J, Seki T, Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Devil Rev 2009; 61(4): 290-302.
15. Khadir A, Verreault J, Averill DA. Inhibition of antioxidants and hyperthermia enhance bleomycin-induced cytotoxicity and lipid peroxidation in Chinese hamster ovary cells. Arch Biochem Biophys 1999; 370(2): 163-175.
16. Conklin KA. Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 2000; 37(1): 1-18.
17. Gon Y, Sasada T, Matsui M, et al. Expression of thioredoxin in bleomycin-injured airway epithelium: Possible role of protection against bleomycin induced epithelial injury. Life sci 2001; 68(16): 1877-1888.
18. Ferreira AL, Matsubara LS, Matsubara BB. Anthracycline-induced cardiotoxicity. Cardiovasc Hematol Agents Med Chem 2008; 6(4): 278-281.
19. Injac R, Strukelj B. Recent advances in protection against doxorubicininduced toxicity. Technol Cancer Res Treat 2008; 7(6): 497-516.
20. Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther 2004; 3(4): 333-341.
21. Sternbach H. Are antidepressants carcinogenic? A review of preclinical and clinical studies. J Clin Psychiatry 2003; 64(10): 1153-1162.
22. Lieb J. Antidepressants, prostaglandins and the prevention and treatment of cancer. Med Hypotheses 2007; 69(3): 684-689.
23. Brambilla G, Mattioli F, Martelli A. Genotoxic and carcinogenic effects of antipsychotics and antidepressants. Toxicology 2009; 261(3): 77-88.
24. Steingart AB, Cotterchio M. Do antidepressants cause, promote, or inhibit cancers? J Clin Epidemiol 1995; 48(11): 1407-1412.
25. Brandes LJ, Arron RJ, Bogdanovic RP, et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 1992; 52(13): 3796-3800.
26. Kubera M, Grygier B, Arteta B, et al. Age-dependent stimulatory effect of desipramine and fluoxetine pretreatment on metastasis formation by B16F10 melanoma in male C57BL/6 mice. Pharmacol Rep 2009; 61(6): 1113-1126.
27. Lieb J. Antidepressants, eicosanoids and the prevention and treatment of cancer. A review. Prostaglandis Leukot Essent Fatty Acids 2001; 65(5-6): 233-239.
28. Adachi M, Sakamoto H, Kawamura R, et al. Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histol Histopathol 2007; 22(4): 437-442.
29. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160(1): 1-40.
30. Lowry OH, Rosenbrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193 265-278.
31. Hunter F, Gebinski J, Hoffstein P, Weinstein J, Scott A. Swelling and lysis of rat liver mitochondria by ferrous ions. J Biol Chem 1963; 238: 828-835.
32. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-522.
33. Gunzler WA, Vergin H, Muller I, Flohe L. Glutathion peroxidase. VI. Die reaction der glutathion peroxidase mit Verschieden hydroperoxiden. Hoppe-Seyler's Z Physiol Chem 1972; 353: 1001-1004.
34. Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and assay applicable to acrylamide gels. Anal Biochem 1971; 44: 276-287.
35. Halliwell B, Grootveld M, Gutteridge J. Methods for the measurement of hydroxyl radicals in biochemical systems: Deoxyribose and aromatic hydroxylation. Methods Biochem Anal 1988; 33: 59-90.
36. Bianchi M, Rossoni G, Sacerdote P, et al. Effects of chlomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat. Inflamm Res 1995; 44(11): 466-469.
37. Abdel-Salam OM, Nofal SM, El-Shenawy SM. Evaluation of the antiinflammatory and anti-nociceptive effects of different antidepressants in the rat. Pharmacol Res 2003; 48(2): 157-165.
38. Abdel-Salam OM, Baiuomy AR, Arbid MS. Studies on the antiinflammatory effect of fluoxetine in the rat. Pharmacol Res 2004; 49(2): 119-131.
39. Roumestan C, Michel A, Bichon F. et al Anti-inflammatory properties of desipramine and fluoxetine. Respir Res 2007; 3; (8): 35.
40. Guemei AA, Nagwa El, Din MN, Baraka AM, El Said, Darwish I. Do desipramine [10,11-dihydro-5-[3-(methylamino) propyl]-5Hdibenz[ b,f]azepine monohydrochloride] and fluoxetine [N-Methyl-3- phenyl-3-[4-(trifluoromethyl) phenoxy]-propan-1-amine] ameliorate the extent of colonic damage induced by acetic acid in rats? J Pharmacol Exp Ther 2008; 327: 846-850.
41. Mostert JP, Admiraal-Behloul F, Hoogduin JM, et al. Effects of fluoxetine on disease activity in relapsing multiple sclerosis: A double-blind, placebo-controlled, exploratory study. J Neurol Neurosurg Psychiatry 2008; 79(9): 1027-1031.
42. McCord JM, Roy RS. The pathophysiology of superoxide: Roles in inflammation and ischemia. Can J Physiol Pharmacol 1982; 60: 1346-1352.
43. Woiniak A, Drewa G, Woźniak B, et al. The effect of antitumor drugs on oxidative stress in B16 and S91 melanoma cells in vitro. Med Sci Monit 2005; 11(1): BR22-BR29.
44. Lu Z, Nie G, Belton PS, Tang H, Zhao B. Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochem Int 2006; 48: 263-274.
45. Dammak I, Boudaya S, Abdallah FB, et al. Date seed oil inhibits hydrogen peroxide-induced oxidative stress in normal human epidermal melanocytes. Connect Tissue Res 2009; 50(5): 330-335.
46. Dong LF, Swettenham E, Eliasson J, et al. Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: The role of oxidative stress. Cancer Res 2007; 67(24): 11906-111193
47. Kim YJ, Kang KS, Yokozawa T. The anti-melanogenic effect of pycnogenol by its anti-oxidative actions. Food Chem Toxicol 2008; 46(7): 2466-2471.